Sale Price: £125.00 (Normally: £156.99). Part 1 A Guide to the Evidence.
1 Rating the Quality of Evidence and Making Recommendations: A Guide to the Spectrum of Clinical Research: Holger J. Sch¨unemann, Martin Stanulla, Jan L. Brozek, Gordon G. Guyatt.

2 An Overview of Systematic Reviews: Martin Prins, Arina ten Cate-Hoek, Pieter Leffers.

3 Interpreting Results in Clinical Research: Overview of measures of effect, measures of precision, and measures of diagnostic accuracy for clinicians and researchers: Marcello Di Nisio, Harry R. B¨uller, Patrick M. M. Bossuyt.

4 Finding the Evidence in Hematology: K. Ann McKibbon, Cynthia J. Walker-Dilks, R. Brian Haynes.

5 Applying EBM in Clinical Practice: Alessandro Squizzato, Walter Ageno, Davide Imberti.

6 Using Evidence to Guide the Diagnosis of Disease: Lucas M. Bachmann, Holger J. Sch¨unemann.

Part 2 Hemostasis and Thrombosis.

7 Diagnosis of Deep Vein Thrombosis: Lori-Ann Linkins.

8 The Diagnosis of Acute Pulmonary Embolism: Victor F. Tapson.

9 Initial Therapy of Deep Vein Thrombosis and Pulmonary Embolism: Sam Schulman.

10 Long-Term Anticoagulation in Venous Thromboembolism: Clive Kearon.

11 Thrombolytic Therapy for Deep Vein Thrombosis and Pulmonary Embolism: Simon J. McRae, John W. Eikelboom.

12 Inferior Vena Cava Interruption: Michael B. Streiff, Christine L. Hann.

13 Management of Venous Thromboembolism in Pregnancy: Wee-Shian Chan.

14 Pediatric Thrombosis: Anthony K. C. Chan, Paul Monagle.

15 Bridging Anticoagulation in PatientsWho Require Temporary Interruption ofWarfarin for Surgery: James D. Douketis, Scott Kaatz.

16 Evidence-based Approach to the Diagnosis and Management of Thrombotic Thrombocytopenic Purpura: Brian Boulmay, Craig S. Kitchens.

17 Diagnosis and Management of Disseminated Intravascular Coagulation: Julia A. M. Anderson.

18 Diagnosis and Management of Hereditary Bleeding Disorders: Including Congenital/Acquired Platelet Function Disorders: Nigel S. Key, Alice D. Ma.

19 Diagnosis and Management of Acquired Bleeding Disorders: Vitamin K Antagonists: Miguel A. Escobar.

20 Diagnosis and Management of Heparin-Induced Thrombocytopenia: Theodore E. Warkentin, Andreas Greinacher.

21 Management of Antiphospholipid Antibody Syndrome: Wendy Lim, Mark A. Crowther.

Part 3 Benign Hematologic Disorders.

22 Clinical Questions in Iron Overload: Antonello Pietrangelo, Nicola Magrini.

23 Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, and Pure Red Cell Aplasia: Shivani Srivastava, Richard W. Childs.

24 Acquired Anemias: Iron Deficiency, Cobalamin Deficiency, and Autoimmune Hemolytic Anemia: Marc S. Zumberg, Marc J. Kahn.

25 Immune Thrombocytopenic Purpura: James N. George, Sara K. Vesely, George R. Buchanan.

26 Neutropenia: David C. Dale.

27 Hypereosinophilia: Primary and Secondary: Florence Roufosse, Michel Goldman, Elie Cogan.

28 Porphyrias: Gagan Sood, Karl E. Anderson.

29 Membrane and Enzyme Abnormalities of the Erythrocyte: Patrick G. Gallagher, Ernest Beutler.

30 Sickle Cell Disease: Richard Lottenberg, Sally C. Davies.

31 Evidence-based Treatment of Thalassemia Major: Issac Odame, Deborah Rund.

Part 4 Malignant Hematologic Disorders.

32 Acute Lymphoblastic Leukemia in Adults: Stephen Couban, Andrea Kew.

33 Acute Myeloid Leukemia in Adults: Remission: Induction Therapy: Cara A. Rosenbaum, Richard A. Larson.

34 Acute Myeloid Leukemia in Adults: Postremission Therapy: Cara A. Rosenbaum, Richard A. Larson.

35 Current Areas of Controversy in the Treatment of Patients With Newly Diagnosed Acute Promyelocytic Leukemia: Martin S. Tallman, Syed A. Abutalib.

36 Chronic Lymphocytic Leukemia: Bruce D. Cheson.

37 Chronic Myeloid Leukemia: Irwin Walker.

38 Selected Management of Patients with Myelodysplastic Syndromes: John M. Storring, Karen W. L. Yee.

39 Evidence-based Treatment of Burkitt Lymphoma in Adults: John Gerecitano, David J. Straus.

40 Primary Central Nervous System Lymphoma: Tamara Shenkier.

41 Diffuse Large B-cell Lymphoma: Michael Crump.

42 Follicular Lymphoma: Kevin Imrie, Matthew Cheung.

43 Lymphoblastic Lymphoma: Tyler Y. Kang, John W. Sweetenham.

44 Mantle Cell Lymphoma: C. Tom Kouroukis.

45 Management of Patients with Peripheral T-cell Lymphoma: Kerry J. Savage.

46 Selected Management Issues of Patients with Hodgkin Lymphoma: Ralph M. Meyer.

47 Lymphocyte Predominant Hodgkin Lymphoma: Brandon McMahon, Jonathan W. Friedberg.

48 Management of Patients with Essential Thrombocythemia: Guido Finazzi, Giovanni Barosi, Tiziano Barbui.

49 Management of Patients with Polycythemia Vera: Guido Finazzi, Roberto Marchioli, Tiziano Barbui.

50 Evidence-based Review of Therapies in Multiple Myeloma: Michael Sebag, A. Keith Stewart.

51 Management ofWaldenstrom’s Macroglobulinemia: Christine I. Chen.

52 The Role of Hematopoietic Growth Factors in Managing Patients with Hematologic Malignancies: Heloisa P. Soares, Ambuj Kumar, Charles Bennett, Benjamin Djulbegovic.

Index